Clinical data was reported for the first time in patients receiving an 8 mg dose per injection (Cohort 9 of the dose escalation portion of RESOLVE), the highest dose planned in this trial. Patients in ...

Clinical data was reported for the first time in patients receiving an 8 mg dose per injection (Cohort 9 of the dose escalation portion of RESOLVE), the highest dose planned in this trial. VICTORIA, ...

The global nonprofit WITNESS seeks to address one of the biggest data gaps in the digital verification landscape: the dependence on tools-based methods that lack local knowledge.

Circle Pharma Announces Poster Presentation Highlighting the Potential of CID-078, a First-in-class Oral Cyclin A/B RxL Inhibitor, at the American Association for Cancer Research Special Conference on ...

Cyclerion Therapeutics, Inc. ( NASDAQ: CYCN) Pioneering a New Era in Neuropsychiatric Therapies Conference September 24, 2025 10:30 AM EDT ...